Aridol Bronchial Challenge Test Kit regulatory update

FDA approved an NDA from Pharmaxis for its Aridol Bronchial Challenge Test Kit to assess bronchial hyperresponsiveness in patients 6 years of age and older who do not have clinically apparent asthma. ...